Back to Selection     Print       Date : 31 May 2025
Fund Summary
DSP Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 30-Nov-2018
Corpus(Cr.) 2961.0 Latest NAV 39.594 As on 09-07-2025
Equity(%) 86.34 52 Week High 41.92
Debt(%) 0.4 52 Week Low 35.056
Others(%) 0.0 Exit Load 0.5% for redemption within 1 month
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.94
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Chirag Dagli
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 39.47%
Top 10 Holdings 62.15%
Top 25 Holdings 96.85%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 70.72
Healthcare 13.46
Global Equity 13.26
Miscellaneous 1.53
Retail 0.63
Cash 0.4
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.90
PE Ratio 41.03
 
Top 25 Holdings
Holdings Net Asset(%)
Cipla Limited 8.86
Cohance Lifesciences Limited 8.81
Sun Pharmaceutical Industries Limited 8.70
IPCA Laboratories Limited 8.16
Gland Pharma Limited 4.94
ALEMBIC PHARMACEUTICALS 4.91
Globus Medical Inc 4.59
Laurus Labs Limited 4.57
Apollo Hospitals Enterprise Limited 4.53
Sai Life Sciences Limited 4.08
Illumina Inc 3.81
Pfizer Limited 3.80
Kovai Medical Center & Hospital Ltd 3.45
Procter & Gamble Health Limited 3.08
Vijaya Diagnostic Centre Limited 3.02
Intuitive Surgical Inc 2.99
Concord Biotech Limited 2.89
Indoco Remedies Limited 2.74
Unichem Laboratories Limited 1.72
Emcure Pharmaceuticals Limited 1.54
ICICI LOMBARD GENERAL INSURANC 1.53
Aarti Drugs Limited 1.28
Abbott Laboratories 1.22
Narayana Hrudalaya Ltd 0.82
Thyrocare Technologies Limited 0.81

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
2.71% 11.66% -3.26% 12.62%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.22% 13.80% 9.05% 5.49%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
28.40% 25.69% 23.25% 0.00%
 
 
15.83% 17.36% 20.09% 13.10%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection